Ironwood Pharmaceuticals IRWD Deferred Tax Assets
Deferred Tax Assets at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxAssetsNet.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's deferred tax assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's deferred tax assets?
- Ironwood Pharmaceuticals (IRWD) reported deferred tax assets of $84.24M in Q1 2026.
- How has Ironwood Pharmaceuticals's deferred tax assets changed year-over-year?
- Ironwood Pharmaceuticals's deferred tax assets decreased by 41.3% year-over-year, from $143.56M to $84.24M.
- What is the long-term trend for Ironwood Pharmaceuticals's deferred tax assets?
- Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's deferred tax assets has grown at a -25.4% compound annual growth rate (CAGR), from $333.29M to $103.43M.
- What does deferred tax assets mean?
- Represents future tax benefits arising from temporary differences between the book value of assets/liabilities and their tax basis, or from carry-forward tax losses. These assets are realized when the firm generates sufficient taxable income to offset these differences. It serves as an indicator of future tax savings potential.